Flindr Therapeutics is a series a startup. 1 investor tracked. Status: possibledead.
Flindr Therapeutics is a startup founded in 2020. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Flindr Therapeutics is developing novel therapeutics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.